E-Book | July 2, 2020

COVID-19 Clinical Trials: A Guidebook For Trial Design And Study Conduct

Source: Worldwide Clinical Trials
COVID 19 Coronavirus

The global COVID-19 pandemic has prompted an unprecedented adjustment to the world of clinical trial development, review and approval timelines, visit management, investigational product supply chains, and reporting requirements.

As sponsors, investigators, and the CROs that support them come to terms with the clinical and operational concerns facing those hoping to conduct COVID-19-related research, Worldwide Clinical Trials has collected its “lessons learned” and expert input based on its ongoing experiences in trial development for COVID-19 studies.

This guidebook aims to provide other research organizations and related entities with valuable insight into effective study planning and execution in these extraordinary times.

access the E-Book!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)